The mechanisms linking CDK12 inactivation to increased intratumoral T cell presence in advanced prostate cancer (18) and the development of preneoplastic lesions with lymphocytic infiltration in the murine prostate epithelium (14) have remained unclear. This evidence concerns the gene CDK12 and prostate carcinoma.